Literature DB >> 1845824

Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.

L C Loh1.   

Abstract

We have characterized the synthesis and processing pathway of the major envelope glycoprotein complex of murine cytomegalovirus (gp52/105/150). We have demonstrated that it belongs to the "late" kinetic class of MCMV proteins, and is initially synthesized as a 128K glycoprotein (gp128) which contains N-linked, high-mannose type oligosaccharide chains and is phosphorylated predominantly at serine residues. A fraction of the gp128 molecules also contains O-linked GalNAc residues. The majority of the gp128 molecules appears to be retained in the endoplasmic reticulum as evidenced by their sensitivity to endoglycosidase H digestion. The formation of disulfide linkages and dimerization allow the transport of gp128 to the Golgi compartments where modification of N-linked carbohydrate structures and extension of O-linked oligosaccharide chains take place, cumulating in the appearance of the mature gp150. The final processing step involves the cleavage of gp150 into gp52 and gp105. By blocking the transport of the glycoprotein precursor to the trans-Golgi compartments with the ionophore monensin, the cleavage process is inhibited, suggesting that the trans-Golgi compartment is the site where gp150 is cleaved. However, the cleavage process is incomplete, resulting in the formation of multiple disulfide-linked complexes made up of different combinations of gp52, gp105, and gp150. Therefore, the processing of the major envelope glycoprotein complexes of murine cytomegalovirus resembles that of the gcl/gp55-116 complex of human cytomegalovirus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845824     DOI: 10.1016/0042-6822(91)90028-a

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells.

Authors:  Jessica Sorem; Richard Longnecker
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

2.  Characterization of a family of structurally related glycoproteins expressing beta 1-6-branched asparagine-linked oligosaccharides in human colon carcinoma cells.

Authors:  S Laferté; L C Loh
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

3.  Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis.

Authors:  Ralitsa S Valchanova; Marcus Picard-Maureau; Matthias Budt; Wolfram Brune
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.

Authors:  Tanja Strive; Eva Borst; Martin Messerle; Klaus Radsak
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus.

Authors:  A Kopp; E Blewett; V Misra; T C Mettenleiter
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.

Authors:  Stefan L Oliver; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

7.  Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.

Authors:  M Rapp; M Messerle; B Bühler; M Tannheimer; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.